Clinical trial
Prothrombin Complex Concentrate for Anticoagulant Reversal
NCT00168077 · CSL Behring, Industry · Completed
Key facts
| NCT number | NCT00168077 |
|---|---|
| Title | Prothrombin Complex Concentrate for Anticoagulant Reversal |
| Official title | Efficacy and Tolerance of BERIPLEX® P/N in Subjects With Acquired Deficiency of Coagulation Factors II, VII, IX and X Due to Oral Anticoagulation |
| Lead sponsor | CSL Behring, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acquired Coagulation Factor Deficiency |
| Intervention type | Drug |
| Interventions | Prothrombin Complex Concentrate |
| Enrollment | 40 |
| Start date | Sep 1, 2005 |
| Completion | Nov 1, 2006 |
| First posted | Sep 14, 2005 |
| Last update posted | Feb 11, 2011 |
| Countries | Austria, Germany, Hungary, Israel, Lithuania, Netherlands, Poland, Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: